Диссертация (1140527), страница 14
Текст из файла (страница 14)
– 2000. – Vol. 101, No 1. – P. 61-66.112.Orange, R.P. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. Modulation byagentsinfluencingcellularlevelsofcyclic3′,5′-adenosinemonophosphate / R.P.Orange, W.G.Austen, K.F.Austen // J Exp Med.– 1971. – Vol.134, Suppl:136s.113.Osadchii, O.E. Cardiac dilatation and pump dysfunction withoutintrinsicmyocardialsystolicfailurefollowingchronicbeta-adrenoreceptor activation / O.E.Osadchii, G.R.Norton, R.McKechnie, etal. // Am J Physiol Heart Circ Physiol.
- 2007. – Vol.292, No 4. –P.H1898–905114.Osborne, M.L. Characteristics of patients with asthma within alarge HMO / M.L.Osborne, W.M.Vollmer, K.L.P.Linton // Am J RespirCrit Care Med. – 1998. – Vol.157. – P.123–128.115.Osuorji, I. Acute stress cardiomyopathy following treatment ofstatus asthmaticus / I.Osuorji, C.Williams, J.Hessney, et al. // Southernmedical journal – 2009. – Vol.102, No 3. – P.301-303108116.Pagani, M. Relationship between spectral components ofcardiovascular variabilities and direct measures of muscle sympatheticnerve activity in humans / M.Pagani, N.Montano, A.Porta, et al. //Circulation. – 1997. – Vol.95, No 6. – P.1441-8.117.Palatini, P.
Association of tachycardia with morbidity andmortality: pathophysiological considerations / P.Palatini, S.Julius // JHum Hypertens. – 1997. – No.11, Suppl 1. – P.S19-27118.Pearce, N. Epidemiologic studies of beta-agonists and asthmadeaths / N.Pearce, M.Hensley // Epidemiologic Reviews. – 1998. –Vol.20, No 2. – P.173-186119.Pears, N.E. Case control study of prescribed fenoterol and deathfrom asthma in New Zealand 1977-1981 / N.E.Pears, J.Grainger,C.Burgess et al. // Thorax. - 1990. - Vol.
45. - №l. - P. 170-175.120.Prior, J.G. Self-poisoning with oral salbutamol / J.G.Prior,G.M.Cochrane, S.M.Raper // Br Med J (Clin Res Ed). – 1981. –Vol.282. – P.1932121.Ramaekers, D. Heart rate variability and heart rate in healthyvolunteers. Is the female autonomic nervous system cardioprotective? //D.Ramaekers, H.Ector, A.E.Aubert // Eur Heart J.
– 1998. – Vol.19, No9. – P.1334-41122.Reunanen,A.Heartrateandmortality/A.Reunanen,J.Karjalainen, P.Ristola, et al. // J Intern Med. – 2000. – Vol.247, No 2.– P.231-9123.Robin, E.D. Sudden cardiac death in bronchial asthma, andinhaled beta-adrenergic agonists / E.D.Robin, R.Mccauley // Chest. –1992. – Vol.101, No 6. – P.1699-702109124.Rosero, S.Z. Asthma and the risk of cardiac events in the long QTsyndrome / S.Z.Rosero, W.Zareba, A.J.Moss, et al. // The Americanjournal of cardiology. - 1999. - Vol.84, No 12. – P.1406-1411125.Rossy L. Fitness and gender-related differences in heart periodvariability / L.Rossy, J.Thayer // Psychosomatic Medicine. – 1998.
–Vol.60, No.6. - P.773-781126.Sa Cunha, R. Association between high heart rate and higharterial rigidity in normotensive and hypertensive subjects / R.SaKunha, B.Pannier, A.Benetos, et al. // J Hypertens. – 1997. – Vol.15. –P.1423–1430127.Saccareccia, F. Heart rate as predictor of mortality: the MATISSproject / F.Saccareccia, et al. // Am. J.
Public Health. - 2001. – Vol.91.– P.1258-1263.128.Schatz, M. The relationship of sex to asthma prevalence, healthcare utilization, and medications in a large managed care organization /M.Schatz, C.A.Camargo Jr. // Ann Allergy Asthma Immunol. – 2003. –Vol.91. – P.553–558.129.Sears, M. The beta 2-agonist controversy. Observations,explanations and relationship to asthma epidemiology / M.Sears,D.Taylor // Drug Saf - 1994. - Vol. 11, No 4.
- P. 259-283130.Seinin M. Hypokalaemia and other non-bronchial effects ofinhaled fenoterol and salbutamol: A placebo-controlled dose-responsestudy in healthy volunteers / M.Seinin, M.Koulu, E. Laurikainen, et al.// Br J Clin Pharmacol. – 1987. – Vol.24. – P.645–53131.Seider, N. Cardiac arrhythmias after inhaled bronchodilators inpatients with COPD and ischemic heart disease / N.Seider,110E.G.Abinader, A. Oliven // Chest. – 1993. – Vol.104, No 4. – P.1070–1074132.Sekerel, B.E.
The effects of inhaled formoterol on the autonomicnervous system in adolescents with asthma / B.E.Sekerel, U.M.Sahiner,M.Can, et al. // Ann Allergy Asthma Immunol. – 2011. – Vol.107, No3. – P.266-72133.Shih, H.T. Frequency and significance of cardiac arrhythmias inchronic obstructive lung disease / H.T.Shih, C.K.Webb, W.A.Conway,et al. // Chest.
– 1988. – Vol.94, No 1. – P.44-48.134.Singer, D.H. Changes in heart rate variability associated withsudden cardiac death. In: Heart rate variability / D.H.Singer, Z.Ori:Futura, 1995. - P.517-531.135.Somsen, G. Cardiac123I-MIBG uptake is affected by variableuptake in reference regions: implications for interpretation in clinicalstudies / G.Somsen, J.Bonn, E.Dubois, et al. // Nucl. Med. Commun.
1996. - Vol. 17. No 10. - P. 872-876136.Speizer, F.E. Observations on recent increase in mortality fromasthma / F.E.Speizer, R.Doll, P.Heaf // Br. Med. J. – 1968. - No1. 335–339.137.Spitzer, W.O. The use of beta-agonists and the risk of death andnear death from asthma / W.O.Spitzer, S.Suissa, P.Ernst, et al. // N.Engl J.
Med. - 1992.-Vol. 326, No 8. - P. 501-506.138.Stein, P.K. Heart rate variability reflects severity of COPD inalpha-antitrypsin deficiency / P.K.Stein, P.Nelson, J.N.Rotthman, et al.// Chest. -1998. - Vol. 113, No 2. - P. 327-333111139.Tan, K.S. Loss of normal cyclical β2 adrenoceptor regulation andincreased premenstrual responsiveness to adenosine monophosphate instablefemaleasthmaticpatients/K.S.Tan,L.C.McFarlane,B.J.Lipworth // Thorax. – 1997. – Vol.52.
– P.608–611140.Tomoda, Y. [Assessment of autonomic nervous activity beforethe onset of paroxysmal atrial fibrillation] / Y.Tomoda, S.Uemura,S.Fujimoto, et al. // J Cardiol. – 1998. – Vol.31, No 1. – P.11-7.141.Troisi, R.J. Menopause, postmenopausal estrogen preparations,and the risk of adult-onset asthma. A prospective cohort study /R.J.Troisi, F.E.Speizer, W.C.Willett, et al // Am J Respir Crit CareMed. – 1995. – Vol.152, 4 Pt, No 1. – P.1183–1188142.Umetani, K.
Twenty-four hour time domain heart rate variabilityand heart rate: relations to age and gender over nine decades /K.Umetany, D.Singer, R.McCraty, et al. // J Am Coll Cardiol. – 1998. –Vol.31. – P.593-601143.van Ravenswaaij-Arts, C.A. Heart rate variability / C.A. vanRavenswaaij-Arts, L.A.Kolle, J.C.Hopman, et al. // Ann of Intern Med.– 1993. - Vol.118. – P.436-47144.Vaughan Williams, E.M.
Cardiac electrophysiological effects ofselective adrenoceptor stimulation and their possible roles inarrhythmias / E.M. Vaughan Williams // J. Cardiovasc. Pharmacol. –1985. – No 7. – P. S61–4145.Vikman S. Altered complexity and correlation properties of R-Rinterval dynamics before the spontaneous onset of paroxysmal atrialfibrillation / S.Vikman, T.H.Mäkikallio, S.Ylimäyry, et al. //Circulation. – 1999. – Vol.100, No 20. – P.2079-84.112146.Vrieze A. Perimenstrual asthma: a syndrome without knowncause or cure / A.Vrieze, D.S.Postma, H.A.Kerstjens // J Allergy ClinImmunol. – 2003. – Vol.112.
– P.271–282147.Warnier, M.J. Resting heart rate is a risk factor for mortality inchronic obstructive pulmonary disease, but not for exacerbations orpneumonia / M.J.Warnier, F.H.Rutten, A.de Boer // PLoS One. – 2014.– Vol.9, No 8. – P. e105152148.Warnier, M.J. Cardiac arrhythmias in adult patients with asthma /M.J.Warnier, F.H.Rutten, J.A.Kors, et al. // Journal of Asthma. – 2012.- Vol.49, No 9.
– P.942-946.149.Westendorp,R.G.Hypoxicsyncope/R.G.Westendorp,G.J.Blauw, M. Frolich // Aviat Space Environ Med. – 1997. – Vol.68. P.410–414150.Williams, S. J. Comparison of inhaled and intravenous terbutalinein acute severe asthma / S.J.Williams, S.J.Winner, T.J.Clark // Thorax.– 1981. – Vol. 36., No.
8. – P. 629-631.151.Williams, T.J. Risk factors for morbidity in mechanicallyventilated patients with acute severe asthma / T.J.Williams, D.V.Tuxen,C.D.Scheinkestel // Am Rev Respir Dis. – 1992. – Vol.146. – P.607–15.152.Wolf, M.M. Sinus arrhythmia in acute myocardial infarction /M.M.Wolf, G.A.Varigos, D.Hunt // Med J Aust. – 1978. - No2. – P.5253153.Wong, C.S. Bronchodilator, cardiovascular, and hypokalaemiceffects of fenoterol, salbutamol, and terbutaline in asthma / C.S.Wong,I.D.Pavord, J.Williams // Lancet.
– 1990. – Vol.336. – P.1396–9113154.Zielinski, J. Causes of death in patients with COPD and chronicrespiratory failure / J.Zielinski, W.MacNee, J.Wedzicha, et al. //Monaldi archives for chest disease. – 1997. – Vol.52, No 1. – P. 43-47114.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
